Howard Shelanski

Davis Polk achieved a significant victory this week for its client, the New York Stock Exchange (“NYSE”), in a dispute between the three largest U.S. stock-exchange groups and the…

Davis Polk advised The Charles Schwab Corporation on its $26 billion all-stock acquisition of TD Ameritrade Holding Corporation.  Under the agreement, TD Ameritrade stockholders…

Davis Polk advised Dean Foods on antitrust and competition aspects of the sale of substantially all of Dean Foods’ assets and business operations pursuant to Section 363 of the Bankruptcy…

Davis Polk advised our client McKesson, working with four other medical equipment suppliers, in obtaining antitrust clearance to work collaboratively to increase the supply of personal…

Davis Polk is advising Natura Cosméticos S.A. on its all-share acquisition of Avon Products, Inc. The transaction, which is expected to close in early 2020, is subject to customary closing…

Davis Polk is advising Aetna in connection with an agreement with the U.S. Department of Justice that allows it to proceed with its proposed $77 billion acquisition by CVS Health and its…

Davis Polk is advising Aetna in connection with an agreement with the U.S. Department of Justice that allows it to proceed with its proposed $77 billion acquisition by CVS Health and its…

Davis Polk is advising Heineken N.V. in connection with its non-binding agreements with China Resources Enterprise (“CRE”) and China Resources Beer (Holdings) Co. Ltd. (“CR Beer”) to create…

Davis Polk is advising Services Group of America on the $1.8 billion sale of its five operating companies collectively known as SGA’s Food Group of Companies to US Foods Holding Corp. The…

Davis Polk is advising Williams on its $1.125 billion combined sale of assets and equity comprising Williams Partners L.P.’s Four Corners Area business in New Mexico and Colorado to Harvest…